Probiotics Administered Intravaginally As a Complementary Therapy Combined with Antibiotics for the Treatment of Bacterial Vaginosis: a Systematic Review Protocol

Overview

Journal BMJ Open

Specialty General Medicine

Date 2017 Oct 18

PMID 29038188

Citations 8

Authors

Liyan Ma

Jianrong Su

Yanli Su

Wei Sun

Zhaoying Zeng

Affiliations

Soon will be listed here.

Abstract

Introduction: Bacterial vaginosis (BV) is a highly prevalent vaginal polymicrobial disorder commonly encountered in women of childbearing age. Therapy with only recommended antibiotics results in low cure rates and unacceptably high recurrence rates. The use of probiotics as a complementary approach for use with antibiotics for the treatment of BV remains unclear. This review aims to assess the efficacy of lactobacilli administered intravaginally in conjunction with antibiotics for the treatment of BV.

Methods And Analysis: The Cochrane Central Register of Controlled Trials in The Cochrane Library, Cochrane Library of Systematic Reviews, Medline/PubMed and Embase will be used to search for articles from database inception to November 2016. Randomised controlled clinical trials using lactobacilli administered intravaginally in conjunction with antibiotics to treat BV will be included. Primary outcome will be the BV cure rate. The recurrence rate will be examined as secondary outcome. Two reviewers will independently select trials and extract data from the original publications. The risk of bias will be assessed according to the Cochrane Risk of Bias tool. We will perform data synthesis using the Review Manager (RevMan) software V.5.2.3. To assess heterogeneity, we will compute the I statistic.

Ethics And Dissemination: This study will be a review of published data and it is not necessary to obtain ethical approval. Findings of this systematic review will be published in a peer-reviewed journal.

Trial Registration Number: International Prospective Register of Systematic Reviews 2014: CRD42014015079.

Citing Articles

Role of Probiotic in Vulvovaginal Candidiasis: A Randomised Controlled Non-blinded Trial from India.

Thekho A, Mendiratta V, Garg T, Kaur R, Yadav V Indian J Dermatol. 2024; 69(5):422.

PMID: 39649975 PMC: 11623429. DOI: 10.4103/ijd.ijd_193_24.

Evaluation of vaginal microbiome equilibrium states identifies microbial parameters linked to resilience after menses and antibiotic therapy.

Lee C, Diegel J, France M, Ravel J, Arnold K PLoS Comput Biol. 2023; 19(8):e1011295.

PMID: 37566641 PMC: 10446192. DOI: 10.1371/journal.pcbi.1011295.

Advancements in the Pharmaceutical Applications of Probiotics: Dosage Forms and Formulation Technology.

Baral K, Bajracharya R, Lee S, Han H Int J Nanomedicine. 2021; 16:7535-7556.

PMID: 34795482 PMC: 8594788. DOI: 10.2147/IJN.S337427.

Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis.

Lee C, Cheu R, Lemke M, Gustin A, France M, Hampel B Nat Commun. 2020; 11(1):6147.

PMID: 33262350 PMC: 7708644. DOI: 10.1038/s41467-020-19880-w.

Acceptability of and treatment preferences for recurrent bacterial vaginosis-Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial.

Anstey Watkins J, Ross J, Thandi S, Brittain C, Kai J, Griffiths F PLoS One. 2019; 14(11):e0224964.

PMID: 31730666 PMC: 6857901. DOI: 10.1371/journal.pone.0224964.

References

Balshem H, Helfand M, Schunemann H, Oxman A, Kunz R, Brozek J . GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011; 64(4):401-6. DOI: 10.1016/j.jclinepi.2010.07.015. View

Forsum U, Hallen A, Larsson P . Bacterial vaginosis--a laboratory and clinical diagnostics enigma. APMIS. 2005; 113(3):153-61. DOI: 10.1111/j.1600-0463.2005.apm1130301.x. View

Ya W, Reifer C, Miller L . Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study. Am J Obstet Gynecol. 2010; 203(2):120.e1-6. DOI: 10.1016/j.ajog.2010.05.023. View

Tomusiak A, Strus M, Heczko P, Adamski P, Stefanski G, Mikolajczyk-Cichonska A . Efficacy and safety of a vaginal medicinal product containing three strains of probiotic bacteria: a multicenter, randomized, double-blind, and placebo-controlled trial. Drug Des Devel Ther. 2015; 9:5345-54. PMC: 4590344. DOI: 10.2147/DDDT.S89214. View

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339:b2535. PMC: 2714657. DOI: 10.1136/bmj.b2535. View

Cohen C, Lingappa J, Baeten J, Ngayo M, Spiegel C, Hong T . Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med. 2012; 9(6):e1001251. PMC: 3383741. DOI: 10.1371/journal.pmed.1001251. View

Tomusiak A, Strus M, Heczko P . [Antibiotic resistance of Gardnerella vaginalis isolated from cases of bacterial vaginosis]. Ginekol Pol. 2012; 82(12):900-4. View

Huang H, Song L, Zhao W . Effects of probiotics for the treatment of bacterial vaginosis in adult women: a meta-analysis of randomized clinical trials. Arch Gynecol Obstet. 2013; 289(6):1225-34. DOI: 10.1007/s00404-013-3117-0. View

Hempel S, Newberry S, Maher A, Wang Z, Miles J, Shanman R . Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012; 307(18):1959-69. DOI: 10.1001/jama.2012.3507. View

10.

Leitich H, Kiss H . Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2007; 21(3):375-90. DOI: 10.1016/j.bpobgyn.2006.12.005. View

11.

Mastromarino P, Vitali B, Mosca L . Bacterial vaginosis: a review on clinical trials with probiotics. New Microbiol. 2013; 36(3):229-38. View

12.

Lamont R, Sobel J, Akins R, Hassan S, Chaiworapongsa T, Kusanovic J . The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG. 2011; 118(5):533-49. PMC: 3055920. DOI: 10.1111/j.1471-0528.2010.02840.x. View

13.

Li J, McCormick J, Bocking A, Reid G . Importance of vaginal microbes in reproductive health. Reprod Sci. 2012; 19(3):235-42. DOI: 10.1177/1933719111418379. View

14.

Bradshaw C, Morton A, Hocking J, Garland S, Morris M, Moss L . High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis. 2006; 193(11):1478-86. DOI: 10.1086/503780. View

15.

Kenyon C, Colebunders R, Crucitti T . The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol. 2013; 209(6):505-23. DOI: 10.1016/j.ajog.2013.05.006. View

16.

Dingens A, Fairfortune T, Reed S, Mitchell C . Bacterial vaginosis and adverse outcomes among full-term infants: a cohort study. BMC Pregnancy Childbirth. 2016; 16(1):278. PMC: 5034665. DOI: 10.1186/s12884-016-1073-y. View

17.

Atashili J, Poole C, Ndumbe P, Adimora A, Smith J . Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS. 2008; 22(12):1493-501. PMC: 2788489. DOI: 10.1097/QAD.0b013e3283021a37. View

18.

Stapleton A, Au-Yeung M, Hooton T, Fredricks D, Roberts P, Czaja C . Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis. 2011; 52(10):1212-7. PMC: 3079401. DOI: 10.1093/cid/cir183. View

19.

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

20.

Oduyebo O, Anorlu R, Ogunsola F . The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst Rev. 2009; (3):CD006055. DOI: 10.1002/14651858.CD006055.pub2. View